复星医药(02196)：吴以芳辞任非执行董事 周旭东辞任高级副总裁

Core Points - Fosun Pharma (02196) announced the resignation of two key executives, Mr. Wu Yifang and Mr. Zhou Xudong, effective September 30, 2025 [1] Group 1 - Mr. Wu Yifang resigned from his position as a non-executive director due to personal work changes, with his resignation effective upon delivery to the board [1] - Mr. Zhou Xudong resigned from his role as Senior Vice President for personal development reasons, effective September 30, 2025 [1]